Rashed Dewan
Vermogen: 572 691 $ op 30-06-2026
Vermogen: 572 691 $ op 30-06-2026
Rashed Dewan is currently Chief Financial Officer at Profound Medical Corp.
since 2022.
Formerly, Mr. Dewan worked as Controller at Profound Medical, Inc. Mr. Dewan completed undergraduate studies at the University of Southern California.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 24-06-2026 | 86.119 ( 0,24% ) | 572 691 $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| PROFOUND MEDICAL CORP. | Financieel Directeur/CFO | 03-03-2022 |
| Bedrijven | Functie | Einde |
|---|---|---|
Profound Medical, Inc.
Profound Medical, Inc. Medical SpecialtiesHealth Technology Develops and commercializes a unique, minimally invasive treatment for prostate cancer | Comptroller/Controller/Auditor | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Profound Medical, Inc.
Profound Medical, Inc. Medical SpecialtiesHealth Technology Develops and commercializes a unique, minimally invasive treatment for prostate cancer | Health Technology |
Profound Medical Corp.
Profound Medical Corp. Medical SpecialtiesHealth Technology Develops and markets medical devices focused on prostate cancer | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau